The partnership aligns Niagen Bioscience’s innovative, science-backed, pharmaceutical-grade NAD+-boosting Niagen products with iCRYO’s clientele, who seek accessible, preventative solutions to maintain long-term health and vitality.
“Niagen IV is now offered at over 900 clinics nationwide, including the new iCRYO locations,” stated Rob Fried, CEO of Niagen Bioscience. “This milestone highlights the growing recognition of Niagen IV and injections as essential tools for supporting healthspan.”
Niagen, Niagen Bioscience’s patented nicotinamide riboside (NR) ingredient, is the most efficient and high-quality NAD+ booster available orally as Tru Niagen®, and as IV and injectable products as Niagen Plus. A coenzyme vital to cellular health, NAD+ is essential for energy, DNA repair, and metabolism; however, levels decline with age and stress. While NAD+ decline has been associated with changes in health and vitality, research demonstrates that restoring NAD+ improves cellular function, metabolic health, and markers of aging.
“We are thrilled to partner with Niagen Bioscience, a global leader in NAD+ research and innovation, to bring their clinically proven Niagen Plus products to iCRYO centers everywhere,” said Kyle Jones, CEO and Co-founder of iCRYO. “This collaboration aligns with our mission to elevate the standard of health, wellness, and longevity globally through cutting-edge solutions that are increasingly more effective and efficient. With Niagen, we are equipping our franchisees and serving our guests with the very best.”
Outperforming NAD+ IV in a pilot clinical study, Niagen IV offers superior tolerability, a 75% shorter infusion time (30-45 minute infusion time for Niagen IV vs several hour infusion time for NAD+ IV), and results in a statistically significant 20% increase in whole blood NAD+ levels three hours post-infusion, as measured by NAD+ dried blood spot tests (MedRxiv). Because NAD+ is not bioavailable and cannot effectively raise NAD+ levels in the body, supplementing with NAD+ itself is not recommended. Furthermore, oral or intravenous NAD+ supplementation has not been well studied in humans, and its safety and efficacy remain unproven. Pharmaceutical-grade Niagen NR is the only clinically validated intravenous solution available for supporting NAD+.
Phil Singer, DO, MBA, FACEP, Chief Medical Officer of iCRYO, commented, “As a physician, I understand the profound impact of NAD+ on cellular function and overall health. Niagen Bioscience’s scientifically validated products, backed by some of the greatest researchers and innovators in the industry, provide our guests with a powerful tool to enhance energy, support metabolic health, and promote longevity, perfectly complementing our commitment to evidence-based solutions. That is why I am personally excited to introduce Niagen into iCRYO’s medical offerings across all our centers.”
By reaching over 900 clinics, including more than 50 iCRYO centers, Niagen Plus enhances nationwide access to clinically validated NAD+-boosting therapies for those seeking to improve cellular health and overall well-being.
To learn more about Niagen IV and injections at iCRYO, visit www.icryo.com. Go to www.niagenplus.com to sign up for product news and updates on future clinic availability and use the store locator function to find a clinic offering Niagen Plus therapies near you.
About Niagen Bioscience
Niagen Bioscience, Inc. (NASDAQ: NAGE), formerly ChromaDex Corp., is the global leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. As a trusted pioneer of NAD+ discoveries, Niagen Bioscience™ is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions.
The Niagen Bioscience team, composed of world-renowned scientists, works with independent investigators from esteemed universities and research institutions around the globe to uncover the full potential of NAD+. A vital coenzyme found in every cell of the human body, NAD+ declines with age and exposure to everyday lifestyle stressors. NAD+ depletion is a key contributor to age-related changes in health and vitality.
Distinguished by state-of-the-art laboratories, rigorous scientific and quality protocols, and collaborations with leading research institutions worldwide, Niagen Bioscience sets the gold standard for research, quality, and innovation. There’s a better way to age.
At the heart of its clinically proven product portfolio is Niagen® (patented nicotinamide riboside, or NR), the most efficient, well-researched, high-quality, and legal NAD+ booster available. Niagen powers the Company’s consumer supplement, Tru Niagen®, the number one NAD+ boosting oral supplement in the United States† (available at www.truniagen.com), and Niagen Plus™, featuring pharmaceutical-grade intravenous (IV) and injectable Niagen products (www.niagenplus.com). Pharmaceutical-grade Niagen IV and injections are compounded and distributed by U.S. FDA-registered 503B outsourcing facilities and are available exclusively at clinics with a prescription.
Niagen Bioscience’s robust patent portfolio protects NR and other NAD+ precursors. Niagen Bioscience maintains a website at www.niagenbioscience.com, where copies of press releases, news, and financial information are regularly published.
†Based on the top-selling dietary supplement brands by revenue per the largest U.S. e-commerce marketplace (as of 1/1/2024 - 12/31/2024).
About iCRYO
Founded in 2015, iCRYO’s mission is to elevate the quality of life of its team members, guests, and franchisees by providing affordable, professional, and convenient personal health services while raising the standard as a global wellness brand.
For more information please visit, www.icryo.com.
